Alternating expiration and inspiration breath-hold spares the chest wall during stereotactic body radiotherapy for peripheral lung malignancies.
Practical Radiation Oncology 2023 Februrary 22
PURPOSE: The proximity of tumors to the chest wall brings additional risks of chest wall pain during stereotactic body radiotherapy (SBRT). Herein, we dosimetrically compared alternated breath-hold (ABH) plans with single BH plans, as well as to determine the common characteristics of eligible patients who may obtain better chest wall sparing using this technique.
METHODS AND MATERIALS: Twenty patients with lung lesions adjacent to the chest wall were enrolled and received respiratory training. Their half-fractions end-expiration (EEBH) and deep inspiration breath-hold (DIBH) plans were summed to generate the ABH plans. Dosimetric parameters of the chest wall were compared between single and alternated BH plans. And the correlation between tumor location and the outcome of chest wall sparing was quantitatively evaluated. Pre-treatment CBCT variations in eligible patients were recorded as well.
RESULTS: Compared to the EEBH and DIBH plans, the ABH plans reduced chest wall dosimetric results with median reductions of 2.0% and 3.9% (Dmax), 15.4% and 14.8% (D1cc), 48.8% and 63% (V30), respectively. Relative tumor displacements (SI/d value) were greater in the lower lobe than in the upper and middle lobes (1.17 vs. 0.18). Meanwhile, better median reductions of 44% (Dmax), 46% (D1cc), and 98% (V30) were obtained in the lower lobe cohort using the ABH technique. Pre-treatment variations for all BHs met the 5 mm threshold.
CONCLUSIONS: The ABH technique can significantly spare the adjacent chest wall without compromising PTV coverage in comparison with the single BH. And patients with tumors in the lower lobes can obtain better chest wall sparing than in the upper and middle lobes. Further investigation is warranted to validate these findings.
METHODS AND MATERIALS: Twenty patients with lung lesions adjacent to the chest wall were enrolled and received respiratory training. Their half-fractions end-expiration (EEBH) and deep inspiration breath-hold (DIBH) plans were summed to generate the ABH plans. Dosimetric parameters of the chest wall were compared between single and alternated BH plans. And the correlation between tumor location and the outcome of chest wall sparing was quantitatively evaluated. Pre-treatment CBCT variations in eligible patients were recorded as well.
RESULTS: Compared to the EEBH and DIBH plans, the ABH plans reduced chest wall dosimetric results with median reductions of 2.0% and 3.9% (Dmax), 15.4% and 14.8% (D1cc), 48.8% and 63% (V30), respectively. Relative tumor displacements (SI/d value) were greater in the lower lobe than in the upper and middle lobes (1.17 vs. 0.18). Meanwhile, better median reductions of 44% (Dmax), 46% (D1cc), and 98% (V30) were obtained in the lower lobe cohort using the ABH technique. Pre-treatment variations for all BHs met the 5 mm threshold.
CONCLUSIONS: The ABH technique can significantly spare the adjacent chest wall without compromising PTV coverage in comparison with the single BH. And patients with tumors in the lower lobes can obtain better chest wall sparing than in the upper and middle lobes. Further investigation is warranted to validate these findings.
Full text links
Trending Papers
The five types of glomerulonephritis classified by pathogenesis, activity, and chronicity (GN-AC).Nephrology, Dialysis, Transplantation 2023 May 23
American Gastroenterological Association-American College of Gastroenterology Clinical Practice Guideline: Pharmacological Management of Chronic Idiopathic Constipation.Gastroenterology 2023 June
The future of intensive care: the study of the microcirculation will help to guide our therapies.Critical Care : the Official Journal of the Critical Care Forum 2023 May 17
Syndrome of Inappropriate Antidiuresis: From Pathophysiology to Management.Endocrine Reviews 2023 March 29
Invasive candidiasis: current clinical challenges and unmet needs in adult populations.Journal of Antimicrobial Chemotherapy 2023 May 24
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app